等待开盘 03-27 09:30:00 美东时间
-1.720
-9.63%
In the fast-paced and highly competitive business world of today, conducting th...
03-26 17:59
Coeur Mining, Inc. ("Coeur" or the "Company") ((NYSE, TSX:CDE) today announced that it has commenced a private exchange offer to certain Eligible Holders (the "Exchange Offer") for any and all of the US$400,000,000
03-23 18:35
Coeur Mining (NYSE:CDE) just disclosed its Q4 earnings on Wednesday, February 1...
02-19 05:34
This whale alert can help traders discover the next big trading opportunities. ...
01-07 01:35
Buffett Sells Stocks
2025-11-04 00:13
10月17日至21日,2025年欧洲肿瘤内科学会(ESMO)年会在德国柏林举行,作为最重要的肿瘤学术会议之一,多家国内药企在会议上发布创新管线的最新临床研究成果...
2025-10-22 21:38
原标题:国产组合,刷新一线治疗UC东亚人群OS历史 自Padcev+K药突破尿路上皮癌一线治疗起,ADC+IO便成为全球创新药开发的下一个趋势,但谁能想到,继...
2025-10-22 17:12
金吾财讯 | 交银国际研报指出,科伦博泰生物(06990)芦康沙妥珠(Sac-TMT)的III期OptiTROP-Lung04研究(二线EGFR突变、TKI治疗进展的NSCLC,Sac-TMT单药对比铂类化疗)结果在ESMO大会公布:Sac-TMT治疗组相比对照组在 PFS 和 OS 上均取得统计学和临床的显著改善:中位 PFS 分别为8.3 vs. 4.2 个月,HR=0.49(95% CI:0.39-0.62,p<0.0001);中位 OS 为 NRvs. 17.4 个月,HR=0.60(95% CI:0.44-0.82,双尾 p=0.001),OS HR 值显著优于同适应症其他各类疗法,...
2025-10-22 16:55